Dr. Aryeh Keehn Designated as a Center of Excellence for GreenLight™ Laser Therapy
Center of Excellence Recognizes High Degree of Experience with New Technology
We’re pleased to announce that Dr. Aryeh Keehn has been designated as a Center of Excellence for GreenLight™ Laser Therapy treatment – a minimally invasive outpatient procedure for men looking to treat their benign prostatic hyperplasia (BPH), not just the symptoms. GreenLight Therapy can help provide immediate relief from enlarged prostate symptoms such as frequent urination—especially at night, weak urine flow, urgency and incomplete bladder emptying. In addition, GreenLight Laser Therapy requires no incisions and typically has no overall deleterious impact on sexual function.1 The Center of Excellence designation recognizes Dr. Keehn’s high degree of experience with GreenLight Laser Therapy and commitment to delivering effective, long-lasting therapy to men suffering from BPH.1
BPH is a condition in which a man’s prostate enlarges and squeezes the urethra, causing frustrating symptoms such as frequent or urgent urination, a weak or interrupted urine stream, and the need to get up several times a night to urinate. It affects about 50% of men by age 60, and up to 90% of men by age 85.2
GreenLight Laser Therapy uses laser energy to vaporize the enlarged tissue, creating an open channel for urine to pass through the urethra. In addition to typically experiencing immediate improvements in urine flow, many patients are pleased to know that GreenLight typically has no overall deleterious impact on sexual function.1 GreenLight Laser therapy is a long-term solution without the need for BPH medication.1
GreenLight Therapy is currently being used in many leading urology practices throughout the United States. To date, more than 1 million patients around the world have been successfully treated with GreenLight Therapy.3
1. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180 W GreenLight-XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570-8.
2. What is BPH? Urology Care Foundation website. https://www.urologyhealth.org/urologic-conditions/benign-prostatic-hyperplasia-(bph).
3. Data on file with Boston Scientific.
* Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
IMPORTANT INFORMATION: These materials are intended to describe common clinical considerations and procedural